Gilead Sciences, Inc.
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for Gilead Sciences, Inc. based on listed parameters only.
The articles listed below published by authors from Gilead Sciences, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Annals of the Rheumatic Diseases |
1 | 0.11 |
Blood |
1 | 0.20 |
Cell Host & Microbe |
1 | 0.06 |
Clinical Infectious Diseases |
4 | 0.63 |
Gut |
2 | 0.35 |
Hepatology |
1 | 0.37 |
JAMA: The Journal of the American Medical Association |
1 | 0.09 |
Journal of Clinical Investigation |
2 | 1.25 |
Journal of Clinical Oncology |
2 | 0.42 |
Journal of Hepatology |
3 | 0.95 |
Journal of Infectious Diseases |
1 | 0.50 |
Nature |
3 | 0.27 |
Nature Communications |
3 | 0.13 |
The Lancet |
2 | 0.40 |
The New England Journal of Medicine |
2 | 0.47 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.